SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63388 357 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61574I agree Jargonweary, also, the data seemed to go south near the end of the trailidahoranch121/27/2023
61573Yep, I have told a lot of people over the years that small cap biotech investingjargonweary31/27/2023
61572Legit concern jargon. Amplified by having less-than-stellar CEO. Of course, weallatwwk-1/27/2023
61571When it comes to how to think about SAVA and Simufilam I am frankly haunted by mjargonweary41/27/2023
61570Nothing really new, but one positive take w/some interesting comments by others.Stanley Lake 92-1/27/2023
61569This is why Technical Writers are paid well. Scientists are often just that, andEMU2-1/27/2023
61568Wow, that was some digging. And yikes!! Years ago, my Dad had all sorts of thinallatwwk31/26/2023
61567Sorry about all the posts. The Trial Summary led me astray. It seems that Joe Spghettogoulash21/26/2023
61566I'm guessing that was just the inclusion criteria for the original 2b study ghettogoulash-1/26/2023
61565Then again, this is clearly worded as an inclusion criteria: a ratio, a specificghettogoulash31/26/2023
61564I just received an email from Mr. Barbier. My conclusion: the screening of theghettogoulash21/26/2023
61563So let's just say the elimination of CSF requirements occurred midway betweeghettogoulash31/26/2023
61562This brings up an interesting point I have been trying to make about Sava's ghettogoulash-1/26/2023
61561The most accurate diagnosis of AD next to post mortem autopsy is CSF biomarkers.ghettogoulash-1/26/2023
61560Yesterday I wrote: (I) added a biopharma to my holdings. Horizon. I bought a ballatwwk-1/26/2023
61559FYI, just to clarify the facts on cognitive degradation: for AD in placebo patiscorman111/26/2023
61558I'm also a bit confused, though somewhat differently than scorman1. I wondeallatwwk-1/25/2023
61557Maybe I am confused...with Trodelvy, the focus was on the 30% who were successfuscorman111/25/2023
61556This was Remi B.'s email response today to an investor on Discord concerningghettogoulash-1/25/2023
61555It's the full data set of 216 patients as a whole. Below is a great explanatghettogoulash11/25/2023
61554Attached are three graphs, taken from Reddit (I know...) with the author's cDavidoff11/25/2023
61553When I see the SAVA results, I'm not clear on one point, perhaps someone canallatwwk21/25/2023
61552SAVA gets another hit piece from anal retentive AF.....he reads the data as not scorman1-1/25/2023
61551AUPH and lawsuit: Old news, but here's the company's press release: Auerickerickson-1/25/2023
61550[graphic]plhky346511/25/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News